Company News

Oral Rinse Reduces SARS-CoV-2

Rowpar Pharmaceuticals to conduct further tests on ClōSys Ultra Sensitive Oral Rinse.

Rowpar Pharmaceuticals Inc., the company behind ClōSys toothpastes, mouthwashes and oral sprays, says that in vitro laboratory analysis has showed that ClōSYS Ultra Sensitive Oral Rinse reduced SARS-CoV-2 (COVID-19 virus) up to 98.4% within 30 seconds without the use of alcohol, hydrogen peroxide or povidone iodine. The study of ClōSys Ultra Sensitive Oral Rinse was conducted at MRI Global, an independent laboratory in Kansas City that is accredited to test infectious viruses like SARS-CoV-2,...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters